The title compound, C 12 H 18 N 4 O 2 , crystallizes in the zwitterionic form with protonation at the N atom of the piperazine ring bearing the carboxylate group. The piperazine ring adopts a slightly distorted chair conformation. In the crystal, N-HÁ Á ÁO hydrogen bonds are observed, forming chains along [010]. The packing is consolidated by C-HÁ Á ÁO interactions, which generate a three-dimensional network.
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S1. Comment
Pyrimidines in general have been of much interest for biological and medical reasons and thus their chemistry has been investigated extensively (Onal & Yıldırım, 2007) and in many drugs used for the treatment of hypothyroidism and hypertension, in cancer chemotherapy or HIV infections (Burdge, 2000) and with related fused heterocyclic compounds that exhibit biological activities such as anticancer (Amin et al., 2009) , antiviral (Ibrahim & El-Metwally, 2010) , antibacterial (Kuyper et al., 1996) and antioxidant (Padmaja et al., 2009) . Some pyrimidinylpiperazinyl compounds like buspirone and BuSpar (Tollefson et al., 1991) are used to treat anxiety. The incorporation of two moieties increases biological activity of both the molecules. Aza-Michael addition reaction has been extensively studied using a variety of catalysts as well as solvents and various researchers have also reported the utility of aza-Michael addition towards the synthesis of various pharmacological active compounds and proved useful in the synthesis of core intermediates of many natural products (Arend et al., 1998) . The role of aza-Michael reaction in the synthesis of pharmacologically important families of β-amino carbonyl compounds and its derivatives is well documented in the literature (Vicario et al., 2005; Xu & Xia, 2005) . Our research group has published many papers on incorporated heterocyclic ring structures, viz; 4-(pyrimidin-2-yl)piperazin-1-ium (E)-3-carboxyprop-2-enoate (Yamuna et al., 2014a) ; flupentixol tartarate (Yamuna et al., 2014b) . Some related zwitterion structures are: 3,3′-(piperazine-1,4-diium-1,4-diyl)dipropionate dihydrate (Jin et al., 2012) , enoxacin trihydrate[1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-4-ium-1-yl)-1,8-naphthyridine-3-carboxylate trihydrate] (Parvez et al., 2004) . In view of the importance of derivatives of the incorporated heterocyclic pyrimidylpiperazines, this paper reports the crystal structure of the title zwitterionic compound, (I), 3-(4-Pyrimidin-2-ylpiperazin-1-ium-1-yl)-butanoate, C 12 H 18 N 4 O 2 prepared from 2-(piperazin-1-yl)pyrimidine and but-2-enoic acid by azaMichael addition reaction.
The title compound, (I), C 12 H 18 N 4 O 2 crystallizes in the zwitterionic form with protonation on the N1 nitrogen atom of the piperazine ring (Fig. 1) . In the compound, the piperazine ring adopts a slightly disordered chair conformation (puckering parameters Q, θ, and φ = 0.576 (2)Å, 3.0 (2)° and 282 (4)°, respectively. Bond lengths are in normal ranges. In the crystal, N-H···O intermolecular hydrogen bonds are observed forming 1D chains along [0 1 0] (Fig. 2) . The packing is consolidated by weak C-H···O interactions which generate a three-dimensional network.
S2. Experimental
A mixture of 1-(2-pyrimidyl)piperazine, from sigma-aldrich (0.2 g, 1.22 mmol) and crotonic acid (but-2-enoic acid) (0.1048 g, 1.22 mmol ) were dissolved in DMSO, stirred well and warmed at 343 K for 20 minutes. After few days, Xray quality crystals were obtained on slow evaporation (m.p.: 411-418 K). 
S3. Refinement
H3 was refined isotropically and all of the remaining H atoms were placed in their calculated positions and then refined using the riding model with Atom-H lengths of 0.95Å (CH); 0.99Å (CH 2 ); 0.98Å (CH 3 ) or 1.00Å (NH). Isotropic displacement parameters for these atoms were set to 1.2 (CH, CH 2 , NH) or 1.5 (CH 3 ) times U eq of the parent atom.
Idealised Me was refined as a rotating group. The title compound was refined as a twin with BASF = 0.41572. Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Refinement. Refined as a 2-component twin. 
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